| (EUR) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 3.35B | 7.10% |
| Operating expense | — | — |
| Net income | 402.00M | 11.98% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, H5P.F returned -4.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +14.1% |
| 1 year | -4.3% |
| 5 years | -22.9% |
| 10 years | -2.9% |
| All-time high | €34.21 (Feb 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in H5P.F would be worth today ›Yes. Hikma Pharmaceuticals PLC paid 2 dividends over the past 12 months. The most recent was €0.33 per share on Aug 13, 2026. The dividend yield is 3.90%.
Hikma Pharmaceuticals PLC is part of the Healthcare sector.
Hikma Pharmaceuticals PLC has a market cap of 3.95B EUR, based on the latest quote.